Figure 1From: Vaccination with a plasmid DNA encoding HER-2/neu together with low doses of GM-CSF and IL-2 in patients with metastatic breast carcinoma: a pilot clinical trialSchematic overview of the Her2-pDNA vaccination schedule.Back to article page